Xin Han

1.5k total citations
59 papers, 1.1k citations indexed

About

Xin Han is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Xin Han has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Epidemiology and 13 papers in Hepatology. Recurrent topics in Xin Han's work include Liver Disease Diagnosis and Treatment (18 papers), Liver physiology and pathology (10 papers) and Extracellular vesicles in disease (5 papers). Xin Han is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Liver physiology and pathology (10 papers) and Extracellular vesicles in disease (5 papers). Xin Han collaborates with scholars based in China, Canada and United States. Xin Han's co-authors include Yan‐Ling Wu, Gang Cao, Qiao Yang, Li‐Hua Lian, Xianan Sang, Ji‐Xing Nan, Shuang Ling, Jin‐Wen Xu, Li Sun and Decheng Lv and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Chemical Engineering Journal.

In The Last Decade

Xin Han

54 papers receiving 1.1k citations

Peers

Xin Han

EPIDE

PHARM

HEPAT

PFM

Laila A. Eissa Egypt

Claudia von Montfort Germany

Xingtao Zhao China

Yong Jin China

Wenwen Wang China

Ke Fu China

Moustafa Fathy Egypt

Jaime Arellanes‐Robledo Mexico

Laila A. Eissa Egypt

Xin Han

399 ×0.9

236 ×0.9

EPIDE

214 ×1.6

PHARM

169 ×1.3

HEPAT

100 ×0.8

PFM

Citations per year, relative to Xin Han Xin Han (= 1×) peers Laila A. Eissa

Countries citing papers authored by Xin Han

Since Specialization

Citations

This map shows the geographic impact of Xin Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Han more than expected).

Fields of papers citing papers by Xin Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Han. The network helps show where Xin Han may publish in the future.

Co-authorship network of co-authors of Xin Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Han. A scholar is included among the top collaborators of Xin Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Han. Xin Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Honglin, Mingjie Pang, Guang‐Hong Chen, et al.. (2025). Panax ginseng exerts cardioprotective effect post myocardial infarction by attenuating myocardial fibrosis and inflammation through SIRT1 signaling pathways. Journal of Ginseng Research. 49(2). 197–207. 3 indexed citations

Liu, Ruina, Jie Dong, Qing‐Hua Xu, et al.. (2025). MCnebula analysis combined with alpha-glucosidase inhibitory screening reveals potential chemical contributors to efficacy enhancement of natural products after processing. Food Research International. 205. 115985–115985.

Wang, Zeping, Xinyue Dou, Qiyuan Shan, et al.. (2025). Targeting AKT to treat liver disease: Opportunities and challenges. Biochemical Pharmacology. 242(Pt 3). 117208–117208.

Zhang, Xiaoqing, Hongyan Dong, Xin Han, et al.. (2025). Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation. Exploration. 5(5). 70000–70000. 1 indexed citations

Han, Xin, et al.. (2024). Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy. Biomedicine & Pharmacotherapy. 179. 117356–117356. 1 indexed citations

Xu, Yin, et al.. (2024). Biomimetic Fe3+ metal-phenolic networks enable DNAzyme and Cas9 RNP delivery for synergistic tumor ferroptosis-immunotherapy. Chemical Engineering Journal. 499. 156050–156050. 1 indexed citations

Han, Xin, Guoyong Zhang, Mingjie Pang, et al.. (2024). Taohong siwu decoction suppresses oxidative stress-induced myocardial apoptosis post-myocardial infarction by inhibiting PTEN pathway. Phytomedicine. 135. 155388–155388. 4 indexed citations

Peng, Mengyun, Hongyan Dong, Chuan Hun Ding, et al.. (2024). Self-heating mitochondrion-induced free radical blast for immunogenic cell death stimulation and HCC immunotherapy. Journal of Controlled Release. 366. 694–711. 3 indexed citations

Ning, Yan, Xinyue Dou, Chuan Hun Ding, et al.. (2024). Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity. Frontiers in Pharmacology. 15. 1370900–1370900. 9 indexed citations

10.

Xie, Lingpeng, Guoyong Zhang, Yuting Wu, et al.. (2024). Protective effects of Wenqingyin on sepsis-induced acute lung injury through regulation of the receptor for advanced glycation end products pathway. Phytomedicine. 129. 155654–155654. 8 indexed citations

11.

Peng, Mengyun, Xin Han, Qiao Yang, et al.. (2023). Nanodrug rescues liver fibrosis via synergistic therapy with H2O2 depletion and Saikosaponin b1 sustained release. Communications Biology. 6(1). 184–184. 16 indexed citations

12.

Lu, Qianglan, Yongchun Pan, Yiqun Jiang, et al.. (2023). Tumor-associated miRNAs activated HCR-DNAzyme theranostic nanosystem to trigger innate- and adaptive-immune responses for long-term immunotherapy. Chemical Engineering Journal. 473. 145192–145192. 9 indexed citations

13.

Wang, Runtian, Peiliang Shen, Chao Chen, et al.. (2023). Boosting immunogenic cell death via hollow MnO2-based multiple stimuli-responsive drug delivery systems for improved cancer immunotherapy. Cancer Nanotechnology. 14(1). 5 indexed citations

14.

Xie, Lingpeng, Chuying Zhou, Yuting Wu, et al.. (2023). Wenqingyin suppresses ferroptosis in the pathogenesis of sepsis-induced liver injury by activating the Nrf2-mediated signaling pathway. Phytomedicine. 114. 154748–154748. 43 indexed citations

15.

Ding, Chuan Hun, Xinyue Dou, Qiao Yang, et al.. (2023). Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis. Aging and Disease. 15(4). 0–0. 12 indexed citations

16.

Xu, Honglin, Guang‐Hong Chen, Guoyong Zhang, et al.. (2023). 20(S)-ginsenoside Rg3 exerts anti-fibrotic effect after myocardial infarction by alleviation of fibroblasts proliferation and collagen deposition through TGFBR1 signaling pathways. Journal of Ginseng Research. 47(6). 743–754. 13 indexed citations

17.

Hao, Min, Xin Han, Han Zhang, et al.. (2022). The pathogenesis of organ fibrosis: Focus on necroptosis. British Journal of Pharmacology. 180(22). 2862–2879. 24 indexed citations

18.

Wang, Yifan, Xiaoqing Zhang, Xin Han, et al.. (2022). From liver fibrosis to hepatocarcinogenesis: Role of excessive liver H2O2 and targeting nanotherapeutics. Bioactive Materials. 23. 187–205. 29 indexed citations

19.

Sang, Xianan, Qiao Yang, Qiyuan Shan, et al.. (2022). The most bioactive fraction of stir-fried Radix Paeoniae Alba regulating IL-6/STAT3 signaling pathway in allergic asthma mouse. Journal of Ethnopharmacology. 301. 115821–115821. 11 indexed citations

20.

Cui, Zhenyu, Xin Han, Yue Liu, et al.. (2021). Allium victorialis L. Extracts Promote Activity of FXR to Ameliorate Alcoholic Liver Disease: Targeting Liver Lipid Deposition and Inflammation. Frontiers in Pharmacology. 12. 738689–738689. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact